Medicare ESRD prospective payment system: weighing the evidence

Editorial

Jonathan Himmelfarb et al. J Am Soc Nephrol. 2005 May.

. 2005 May;16(5):1164-5.

doi: 10.1681/ASN.2005030315. Epub 2005 Apr 13.

No abstract available

Comment on

Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.
Xue JL, Ma JZ, Louis TA, Collins AJ. Xue JL, et al. J Am Soc Nephrol. 2001 Dec;12(12):2753-2758. doi: 10.1681/ASN.V12122753. J Am Soc Nephrol. 2001. PMID: 11729245
Payment for quality in end-stage renal disease.
Himmelfarb J, Pereira BJ, Wesson DE, Smedberg PC, Henrich WL. Himmelfarb J, et al. J Am Soc Nephrol. 2004 Dec;15(12):3263-9. doi: 10.1097/01.ASN.0000145893.61791.7B. J Am Soc Nephrol. 2004. PMID: 15579531 Review. No abstract available.
Economic impact of case-mix adjusting the dialysis composite rate.
Hirth RA, Roys EC, Wheeler JR, Messana JM, Turenne MN, Saran R, Pozniak AS, Wolfe RA. Hirth RA, et al. J Am Soc Nephrol. 2005 May;16(5):1172-6. doi: 10.1681/ASN.2004110950. Epub 2005 Mar 30. J Am Soc Nephrol. 2005. PMID: 15800122